Home » Topics » BioWorld Science, Patents

BioWorld Science, Patents
RSS

Novel candidate anticancer drugs patented by Portola Pharmaceuticals

June 7, 2012

Novel protein kinase inhibitors divulged

June 6, 2012

Research at U.S. university yields new anticancer agents

June 6, 2012

Bayer designs novel guanylate cyclase activators

June 6, 2012

Portola Pharmaceuticals presents new SYK inhibitors

June 6, 2012

Novel candidate cancer therapies created at Aurigene Discovery Technologies

June 6, 2012

Researchers at Marine Polymer Technologies patent new potential melanoma vaccines

June 5, 2012

Novel treatments for IBD prepared by Spanish team

June 5, 2012

GlaxoSmithKline discovers new LDH-A inhibitors

June 5, 2012

Theravance discloses novel candidate hepatitis C therapies

June 5, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 5, 2025.
MicroRNAs in circulating extracellular vesicles as IPF biomarkers
BioWorld Science
MicroRNAs (miRNAs) are small noncoding RNAs gaining increasing attention due to their crucial role in gene expression regulation and influence in various cellular...
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Study identifies CAND1 as therapeutic target in hepatoblastoma
BioWorld Science
Hepatoblastoma is the most common liver cancer during childhood, with limited therapeutic options in aggressive or relapsed cases. NEDDylation is a...